Nanopublications

@prefix ns1: <http://purl.org/np/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RARS89NGDA97NeYA8SjSuqaNQ-cC3isoW4xu8NpbnhhoE> .
@prefix sub: <http://purl.org/np/RARS89NGDA97NeYA8SjSuqaNQ-cC3isoW4xu8NpbnhhoE#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix nkg: <https://w3id.org/um/neurodkg/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}

sub:assertion {
  sub:association rdf:object <https://identifiers.org/MONDO:0013600> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/CHEBI:6539> ;
    a rdf:Statement ;
    rdfs:label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated" ;
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    bl:has_population_context sub:cohort ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:publications <https://pubmed.ncbi.nlm.nih.gov/30422485/> ;
    bl:relation nkg:OffLabelIndication .
  sub:cohort rdfs:label "Adults" ;
    bl:category bl:Cohort .
  <https://identifiers.org/CHEBI:6539> bl:category bl:Drug .
  <https://identifiers.org/MONDO:0013600> bl:category bl:Disease .
}

sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" ;
    npx:hasSignature "EQf8QvVM1uk4Rw8eAiHiR6yP981Fprj9jO7YIrF014Psjl/1m0FdNrTNp8QWc2gKSIxY7XFgzMnsWLzbEfOymPJtkGce2w0QBMXX5XoC4W9xOpxDjtrpn8pIcB1jxJgVB5sJ2XhHB/l92Tr6vec+5awY1X3urWN1uFesjIhBEnE=" ;
    npx:hasSignatureTarget this: .
  this: dcterms:created "2021-03-24T16:50:06.579+01:00"^^xsd:dateTime ;
    dcterms:creator orcid:0000-0002-7641-6446 ;
    nt:wasCreatedFromProvenanceTemplate ns1:RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM ;
    nt:wasCreatedFromPubinfoTemplate ns1:RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM ;
    nt:wasCreatedFromTemplate ns1:RANZiWwik7Dn1hm5mfQEe4swx7quqnpS9VWLzIdYvRfsc .
}